Instadose Pharma (Instadose Pharma) Pre-Tax Income : $-1.36 Mil (TTM As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Instadose Pharma's pretax income for the three months ended in Feb. 2022 was $-0.91 Mil. Its pretax income for the trailing twelve months (TTM) ended in Feb. 2022 was $-1.36 Mil. Instadose Pharma's pretax margin was %.

Instadose Pharma Pre-Tax Income Historical Data

The historical data trend for Instadose Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Pre-Tax Income Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Pre-Tax Income

Get a 7-Day Free Trial

-0.03

-0.02

-0.03

-0.47

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Pre-Tax Income	Get a 7-Day Free Trial															-10.47	-0.05	-0.05	-0.36	-0.91

Competitive Comparison of Instadose Pharma's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instadose Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Pre-Tax Income falls into.

Instadose Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Instadose Pharma's Pretax Income for the fiscal year that ended in Nov. 2021 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.469	+	0	+	0	+	0	+	0
	=	-0.47

Instadose Pharma's Pretax Income for the quarter that ended in Feb. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.885	+	-0.021	+	0	+	0	+	0
	=	-0.91

Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.36 Mil.

Instadose Pharma (OTCPK:INSD) Pre-Tax Income Explanation

Instadose Pharma's Pretax Margin for the quarter that ended in Feb. 2022 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.906	/	0
	=	%

Instadose Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.